Stockreport

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF Reports full year 2023 revenue of $50.6 million and non-GAAP adjusted EBITDA loss of $11.6 millionReaffirms expected release of topline pivotal clinical data for Anaphyl [Read more]